These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Outcomes After Implantable Cardioverter-Defibrillator Generator Replacement for Primary Prevention of Sudden Cardiac Death. Madhavan M, Waks JW, Friedman PA, Kramer DB, Buxton AE, Noseworthy PA, Mehta RA, Hodge DO, Higgins AY, Webster TL, Witt CM, Cha YM, Gersh BJ. Circ Arrhythm Electrophysiol; 2016 Mar; 9(3):e003283. PubMed ID: 26921377 [Abstract] [Full Text] [Related]
3. Mortality Implications of Appropriate Implantable Cardioverter Defibrillator Therapy in Secondary Prevention Patients: Contrasting Mortality in Primary Prevention Patients From a Prospective Population-Based Registry. Almehmadi F, Porta-Sánchez A, Ha ACT, Fischer HD, Wang X, Austin PC, Lee DS, Nanthakumar K. J Am Heart Assoc; 2017 Aug 19; 6(8):. PubMed ID: 28862957 [Abstract] [Full Text] [Related]
5. Impact of Improved Left Ventricular Systolic Function on the Recurrence of Ventricular Arrhythmia in Heart Failure Patients With an Implantable Cardioverter-Defibrillator. Kim M, Kim J, Lee JH, Hwang YM, Kim MS, Nam GB, Choi KJ, Kim JJ, Kim YH. J Cardiovasc Electrophysiol; 2016 Oct 19; 27(10):1191-1198. PubMed ID: 27334231 [Abstract] [Full Text] [Related]
6. Risk of Appropriate Therapy and Death Before Therapy After Implantable Cardioverter-Defibrillator Generator Replacement. Witt CM, Waks JW, Mehta RA, Friedman PA, Kramer DB, Buxton AE, Mulpuru SK, Noseworthy PA, Hodge DO, Lushinsky EC, Mulholland MB, Cha YM, Gersh BJ, Madhavan M. Circ Arrhythm Electrophysiol; 2018 Aug 19; 11(8):e006155. PubMed ID: 30354311 [Abstract] [Full Text] [Related]
13. Implantable cardioverter defibrillator for primary prevention in patients with severe ventricular dysfunction awaiting heart transplantation. Cantero-Pérez EM, Sobrino-Márquez JM, Grande-Trillo A, Lage-Gallé E, Rangel-Sousa D, Esteve-Ruiz IM, Martínez-Martínez A. Transplant Proc; 2013 Nov 19; 45(10):3659-61. PubMed ID: 24314988 [Abstract] [Full Text] [Related]
14. Prognostic impact of chronic total coronary occlusion on long-term outcomes in implantable cardioverter-defibrillator recipients with ischaemic heart disease. Nishikawa T, Fujino M, Nakajima I, Asaumi Y, Kataoka Y, Anzai T, Kusano K, Noguchi T, Goto Y, Nishimura K, Miyamoto Y, Kiso K, Yasuda S. Europace; 2017 Jul 01; 19(7):1153-1162. PubMed ID: 27738062 [Abstract] [Full Text] [Related]
17. Contemporary rates and outcomes of single- vs. dual-coil implantable cardioverter defibrillator lead implantation: data from the Israeli ICD Registry. Leshem E, Suleiman M, Laish-Farkash A, Konstantino Y, Glikson M, Barsheshet A, Goldenberg I, Michowitz Y, Israeli Working Group of Pacing and
Electrophysiology. Europace; 2017 Sep 01; 19(9):1485-1492. PubMed ID: 27702848 [Abstract] [Full Text] [Related]
20. Incidence of appropriate anti-tachycardia therapies after elective generator replacement in patient with heart failure initially implanted with a defibrillator for primary prevention: Results of a meta-analysis. Rordorf R, Cornara S, Klersy C, Savastano S, Vicentini A, Sanzo A, Petracci B, Ghio S, Oltrona Visconti L, De Ferrari GM. Int J Cardiol; 2019 May 15; 283():122-127. PubMed ID: 30638746 [Abstract] [Full Text] [Related] Page: [Next] [New Search]